Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.36 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | NPY4R | P50391 | 8/20 | 0.34 |
| ▸ | NPY1R | P25929 | 5/20 | 0.34 |
| ▸ | NPY2R | P49146 | 3/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.34 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL1551710 | 1.00 | FOLH1 (0.39) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| Acetic Acid SCHEMBL2170653 | 1.00 | FOLH1 (0.39) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| SCHEMBL17769024 | 0.97 | FOLH1 (0.38) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| SCHEMBL162756 | 0.97 | FOLH1 (0.38) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| SCHEMBL93473 | 0.97 | FOLH1 (0.38) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| SCHEMBL93472 | 0.97 | FOLH1 (0.38) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| Acetic Acid SCHEMBL4407896 | 0.95 | FOLH1 (0.44) | FOLH1ALOX15MEN1KMT2ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL1578565 | 0.95 | FOLH1 (0.37) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| Hydrochloric Acid SCHEMBL974818 | 0.95 | FOLH1 (0.37) | FOLH1ITGB3ITGA2BC3AR1ALOX15 | |
| Hydrochloric Acid SCHEMBL7367067 | 0.95 | FOLH1 (0.37) | FOLH1ITGB3ITGA2BC3AR1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 445 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109382756-B | Chemical mechanical polishing method for tungsten | 罗门哈斯电子材料CMP控股股份有限公司 | 2021-07-30 | — | — | CN | claimed |
| CN-111760472-A | Composite membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2020-10-13 | — | — | CN | claimed |
| CN-111760473-A | Composite semipermeable membrane, preparation method and application | 中国石油化工股份有限公司 | 2020-10-13 | — | — | CN | claimed |
| US-10600655-B2 | Chemical mechanical polishing method for tungsten | ROHM AND HAAS ELECTRONIC MATERIALS CMP HOLDINGS, INC. (US) | 2020-03-24 | — | — | US | claimed |
| US-8183409-B2 | High yield and rapid synthesis methods for producing metallo-organic salts | OSTEOLOGIX A/S (DK) | 2012-05-22 | — | — | US | claimed |
| US-20090298747-A1 | Methods and Compositions For Treatment of Nitric Oxide-Induced Clinical Conditions | BIO HOLDING, INC. (US) | 2009-12-03 | — | — | US | claimed |
| US-20090291926-A1 | HIGH YIELD AND RAPID SYNTHESIS METHODS FOR PRODUCING METALLO-ORGANIC SALTS | CHRISTGAU STEPHAN | 2009-11-26 | — | — | US | claimed |
| US-20080317849-A1 | Method for Improving the Medical Treatment of Pain | OSTEOLOGIX A/S (DK) | 2008-12-25 | — | — | US | claimed |
| US-20070282127-A1 | High Yield And Rapid Synthesis Methods For Producing Metallo-Organic Salts | OSTEOLOGIX A/S | 2007-12-06 | — | — | US | claimed |
| CN-101010087-A | High yield and rapid synthesis method for processing organic metal salt | VKR HOLDING AS SOBORG (DK) | 2007-08-01 | — | — | CN | claimed |
| EP-1758652-A2 | IMPROVING PAIN TREATMENT WITH STRONTIUM COMBINATIONS | Osteologix A/S (DK) | 2007-03-07 | — | — | EP | claimed |
| EP-1744770-A2 | HIGH YIELD AND RAPID SYNTHESES METHODS FOR PRODUCING METALLO-ORGANIC SALTS | Osteologix A/S (DK) | 2007-01-24 | — | — | EP | claimed |
| WO-2005123192-A2 | IMPROVING PAIN TREATMENT WITH STRONTIUM COMBINATIONS | OSTEOLOGIX A/S (DK) | 2005-12-29 | — | — | WO | claimed |
| WO-2005108339-A2 | HIGH YIELD AND RAPID SYNTHESES METHODS FOR PRODUCING METALLO-ORGANIC SALTS | OSTEOLOGIX A/S (DK) | 2005-11-17 | — | — | WO | claimed |
| US-6864086-B2 | Nitric oxide-scavenging system for culturing oocytes, embryos, or other cells | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2005-03-08 | — | — | US | claimed |
| US-20040220113-A1 | Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions | BIO HOLDING, INC. | 2004-11-04 | — | — | US | claimed |
| US-20040220242-A1 | Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions | BIO HOLDING, INC. | 2004-11-04 | — | — | US | claimed |
| WO-1995028081-A1 | ADDRESSING BAIT AVERSION BY DISRUPTING ASSOCIATIVE LEARNING | THE MEAT INDUSTRY RESEARCH INSTITUTE OF NEW ZEALAND INC. (NZ) | 1995-10-26 | — | — | WO | claimed |
| CN-118373794-B | Isoflavone compound, preparation method thereof and application thereof in pharmacy | 中国中医科学院中药研究所 | 2025-08-29 | — | — | CN | disclosed |
| WO-1992020325-A1 | ENGINEERING THE LOCAL INFLAMMATORY RESPONSE AS A MEANS OF CONTROLLED RELEASE DRUG DELIVERY | ENDOCON, INC. (US) | 1992-11-26 | — | — | WO | disclosed |